鄭斌男

Doctor

內科部

電子郵件pncheng@mail.ncku.edu.tw

來源：Scopus
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。

每年研究成果

如果您對這些純文本內容做了任何改變，很快就會看到。

個人檔案

學歷

中山醫學院醫學系學士

經歷

1992年08月 ~迄今胃腸肝膽科醫師

指紋

查看啟用 Pin-Nan Cheng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

21 類似的個人檔案

網路

國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。

1 已完成

直接抗病毒藥物治療慢性C型肝炎對脂質、J載脂蛋白、主動脈硬度和心血管疾病風險的長期影響
Cheng, P.
19-08-01 → 20-07-31
研究計畫: Research project

782 引文
15 h-指數
74 Article
2 Review article

Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C
Chen, J. Y., Cheng, P. N., Chiu, Y. C., Chiu, H. C., Tsai, W. C. & Tsai, L. M., 2021 一月, 於: Journal of Viral Hepatitis. 28, 1, p. 159-167 9 p.
研究成果: Article › 同行評審

開啟存取
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry
Wu, H. Y., Pan, Y. Y., Kopylov, A. T., Zgoda, V., Ma, M. C., Wang, C. H., Su, W. C., Lai, W. W., Cheng, P. N. & Liao, P. C., 2020 七月 1, 於: Proteomics - Clinical Applications. 14, 4, 1900095.
研究成果: Article › 同行評審
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
Chiu, H. C., Chiu, Y. C., Yang, E. H., Chang, T. T., Chien, S. C., Wu, I. C., Wu, C. H. & Cheng, P. N., 2020, (Accepted/In press) 於: Journal of the Formosan Medical Association.
研究成果: Article › 同行評審

開啟存取
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
Cheng, P. N., Chen, C. Y., Yu, M. L., Lin, C. C., Lin, C. Y., Peng, C. Y., Tseng, K. C., Lo, C. C., Tseng, I. H. & Liu, C. J., 2020, (Accepted/In press) 於: Journal of Microbiology, Immunology and Infection.
研究成果: Article › 同行評審

開啟存取
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Huang, C. F., Lai, H. C., Chen, C. Y., Tseng, K. C., Kuo, H. T., Hung, C. H., Wang, J. H., Chen, J. J., Lee, P. L., Chien, R. N., Yang, C. C., Lo, G. H., Tai, C. M., Lin, C. W., Kao, J. H., Liu, C. J., Liu, C. H., Yan, S. L., Bair, M. J., Lin, C. Y. 及其他19, Su, W. W., Chu, C. H., Chen, C. J., Tung, S. Y., Lo, C. C., Cheng, P. N., Chiu, Y. C., Wang, C. C., Cheng, J. S., Tsai, W. L., Lin, H. C., Huang, Y. H., Yeh, M. L., Huang, J. F., Dai, C. Y., Chuang, W. L., Tsai, P. C., Peng, C. Y. & Yu, M. L., 2020 八月 1, 於: The American journal of gastroenterology. 115, 8, p. 1226-1235 10 p.
研究成果: Article › 同行評審
2 引文斯高帕斯（Scopus）

學歷

經歷

直接抗病毒藥物治療慢性C型肝炎對脂質、J載脂蛋白、主動脈硬度和心血管疾病風險的長期影響

Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C

Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)